메뉴 건너뛰기




Volumn 73, Issue 12, 2002, Pages 1179-1182

Treatment of hip adductor spasticity with botullinum toxin type B;Behandlung der adduktorenspastik mit botulinumtoxin typ B

Author keywords

Adductor muscles; Botulinum toxin; Spasticity

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

EID: 0036935592     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-002-1392-2     Document Type: Article
Times cited : (8)

References (14)
  • 1
    • 0002443931 scopus 로고
    • Botulinum toxin for spasms and spasticity in the lower extremities
    • Jankovic J, Hallett M (eds). Marcel Dekker Inc, New York
    • Benecke R (1994) Botulinum toxin for spasms and spasticity in the lower extremities. In Jankovic J, Hallett M (eds) Therapy with Botulinum Toxin. Marcel Dekker Inc, New York, pp 557-565
    • (1994) Therapy with Botulinum Toxin , pp. 557-565
    • Benecke, R.1
  • 2
    • 0032718516 scopus 로고    scopus 로고
    • Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia
    • Brashear A, Lew MF, Dykstra DD et al. (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 53:1439-46
    • (1999) Neurology , vol.53 , pp. 1439-1446
    • Brashear, A.1    Lew, M.F.2    Dykstra, D.D.3
  • 3
    • 0032716402 scopus 로고    scopus 로고
    • Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia
    • Brin MF, Lew MF, Adler CH et al. (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 53:1431-8
    • (1999) Neurology , vol.53 , pp. 1431-1438
    • Brin, M.F.1    Lew, M.F.2    Adler, C.H.3
  • 4
    • 0036481152 scopus 로고    scopus 로고
    • Erste erfahrungen mit der klinischen anwendung von botulinum-toxin typ B
    • Dressler D, Benecke R (2002) Erste Erfahrungen mit der klinischen Anwendung von Botulinum-Toxin Typ B. Nervenarzt 73:194-8
    • (2002) Nervenarzt , vol.73 , pp. 194-198
    • Dressler, D.1    Benecke, R.2
  • 5
    • 0031776446 scopus 로고    scopus 로고
    • Mouse bioassay versus Western blot assay for botulinum toxin antibodies. Correlation with clinical response
    • Hanna PA, Jankovic J (1998) Mouse bioassay versus Western blot assay for botulinum toxin antibodies. Correlation with clinical response. Neurology 50:1624-9
    • (1998) Neurology , vol.50 , pp. 1624-1629
    • Hanna, P.A.1    Jankovic, J.2
  • 6
    • 0036010372 scopus 로고    scopus 로고
    • Management of upper and lower limb spasticity in neuro-rehabilitation
    • Hesse S, Werner C, Bardeleben A et al. (2002) Management of upper and lower limb spasticity in neuro-rehabilitation. Acta Neurochir [Suppl 79]:117-22
    • (2002) Acta Neurochir , Issue.SUPPL. 79 , pp. 117-122
    • Hesse, S.1    Werner, C.2    Bardeleben, A.3
  • 7
    • 0034067174 scopus 로고    scopus 로고
    • Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: A prospective, randomised, double-blind, placebo-controlled, dose ranging study
    • Hyman N, Barnes M, Bhaka B et al. (2000) Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double-blind, placebo-controlled, dose ranging study. J Neurol Neurosurg Psychiatry 68:707-12
    • (2000) J Neurol Neurosurg Psychiatry , vol.68 , pp. 707-712
    • Hyman, N.1    Barnes, M.2    Bhaka, B.3
  • 8
    • 0034719053 scopus 로고    scopus 로고
    • The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: Summary of three controlled trials
    • Lew MF, Brashear A, Factor S (2000) The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: Summary of three controlled trials. Neurology 55 [Suppl 5]:29-35
    • (2000) Neurology , vol.55 , Issue.SUPPL. 5 , pp. 29-35
    • Lew, M.F.1    Brashear, A.2    Factor, S.3
  • 9
    • 19044367525 scopus 로고    scopus 로고
    • Botulinum toxin A (BoNT-A) for spasticity in adults. What is the evidence?
    • Moore AP (2002) Botulinum toxin A (BoNT-A) for spasticity in adults. What is the evidence? Eur J Neurol 9 [Suppl 1]:42-7
    • (2002) Eur J Neurol , vol.9 , Issue.SUPPL. 1 , pp. 42-47
    • Moore, A.P.1
  • 10
    • 0035074163 scopus 로고    scopus 로고
    • Botulinum toxin for treatment of spasticity in adults
    • Reichel G (2001) Botulinum toxin for treatment of spasticity in adults. J Neurol 248 [Suppl 1]: 1/25-1/27
    • (2001) J Neurol , vol.248 , Issue.SUPPL. 1 , pp. 125-127
    • Reichel, G.1
  • 11
    • 0034719038 scopus 로고    scopus 로고
    • The biochemistry of botulinum toxin type B
    • Settler P (2000) The biochemistry of botulinum toxin type B. Neurology 55 [Suppl 5]:22-28
    • (2000) Neurology , vol.55 , Issue.SUPPL. 5 , pp. 22-28
    • Settler, P.1
  • 12
    • 0035687163 scopus 로고    scopus 로고
    • Botulinum treatment of spasticity: Why is it so difficult to show a functional benefit?
    • Sheean GL (2001) Botulinum treatment of spasticity: why is it so difficult to show a functional benefit? Curr Opin Neurol 14:771-6
    • (2001) Curr Opin Neurol , vol.14 , pp. 771-776
    • Sheean, G.L.1
  • 13
    • 0025000163 scopus 로고
    • Treatment of spasticity with botulinum toxin: A double-blind study
    • Snow BJ, Tsui JK, Bhatt MH et al. (1990) Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 28:512-5
    • (1990) Ann Neurol , vol.28 , pp. 512-515
    • Snow, B.J.1    Tsui, J.K.2    Bhatt, M.H.3
  • 14
    • 19044383212 scopus 로고    scopus 로고
    • A summary of spasticity management - A treatment algorithm
    • Ward AB (2002) A summary of spasticity management - a treatment algorithm. Eur J Neurol 9 [Suppl 1]:48-52
    • (2002) Eur J Neurol , vol.9 , Issue.SUPPL. 1 , pp. 48-52
    • Ward, A.B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.